Chondroprotec is a sterile solution used to aid in the treatment of wounds, lesions, burns and other trauma in horses, dogs and cats. It contains polysulfated glycosaminoglycan such as adequan. Each 10 ml of Chondroprotec contains 1000 mg polysulfated glycosaminoglycan. Chondroprotec is indicated for use in the treatment of secreting and bleeding dermal lesions, first and second degree burns, trauma injuries, pressure ulcers, Venous Statis ulcers, donor sites and partial and full thickness wounds. Reapply daily and redress wound site every 5-7 days or as needed. Polysulfated glycosaminoglycan.
Chondroprotec is a polysulfated glycosaminoglycan sterile solution that is used in treating wounds. It is a patented technology derived from bovine trachea that contains glycosaminoglycans that support or enhance the connective tissue matrix and, as such, are found in the chemical composition of connective and soft tissues in humans and animals.
The compounds in Chondroprotec are beneficial in the management of chronic and acute wounds. Polysulfated glycosaminoglycans rehydrate dry wounds, maintain a moist healing environment, and protect from tissue trauma. Chondroprotec has been shown to be most effective in the earliest stages of the healing process, the granulation and wound contraction stages. It is used in treating first and second degree burns, partial and full thickness wounds, secreting and bleeding dermal lesions, trauma injuries, pressure ulcers, and surgical incisions.
Dosage and Administration
Chondroprotec is packaged in a sterile until opened 10 ml vial ready to be applied directly to the wound. The wound site should be irrigated with sterile water or a normal saline solution. Apply liberally to wound surface. Cover with gauze or a non-stick pad. Re-dress wound site every 24 to 48 hours as needed. Follow veterinarian’s and manufacturer’s directions in each individual situation.
Not for use in animals used for food. Federal law restricts this product to be used by or on the order of a licensed veterinarian.
No information available.
No USEF prohibitions known at this time.